Literature DB >> 20868565

Imbalance of Th17 to Th1 cells in Behçet's disease.

Jinhyun Kim1, Ji Ah Park, Eun Young Lee, Yun Jong Lee, Yeong Wook Song, Eun Bong Lee.   

Abstract

OBJECTIVES: Behçet's disease (BD) is a helper T cell-mediated autoimmune disease characterised by recurrent orogenital ulcers, uveitis and skin lesions. The helper T cells are divided into Th1, Th2 and Th17 cells according to the pattern of cytokine secretion. Th1 and Th17 cells can contribute to the development of the disease with their respective proinflammatory cytokines, IFN-γ and IL-17. In this study, we investigated the relative role of Th17, Th1 and Th2 cells in BD.
METHODS: Peripheral blood mononuclear cells were isolated from 30 patients with BD, for whom the detailed clinical manifestations and medication history were investigated and recorded. Surface markers and intracellular levels of IL-17, IFN-γ and IL-4 in isolated CD4+ T cells were measured using flow-cytometry from these patients and from two control groups, 34 rheumatoid arthritis patients and 24 healthy blood donors to analyse the relationship of Th1, Th17 and Th2 cells in BD.
RESULTS: The ratio of Th17/Th1 cells was significantly increased in BD compared to healthy controls (0.16±0.09 vs. 0.10±0.04, p=0.012), while there was no difference in the ratios of Th1/Th2 or Th17/Th2 cells. Th17/Th1 ratio was elevated in BD patients with uveitis or folliculitis compared to those without it (0.21±0.10 vs. 0.13±0.06, p=0.045 for uveitis; 0.18±0.10 vs. 0.12±0.05, p=0.036 for folliculitis).
CONCLUSIONS: Our results confirm that TH17 cells are instrumental in Behçet's uveitis and folliculitis. Furthermore, our findings suggest that the role of Th17 cells should be interpreted in the context of their ratio to Th1 cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20868565

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  26 in total

Review 1.  Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review.

Authors:  Jurgen Sota; Donato Rigante; Giuseppe Lopalco; Bruno Frediani; Rossella Franceschini; Mauro Galeazzi; Florenzo Iannone; Gian Marco Tosi; Claudia Fabiani; Luca Cantarini
Journal:  Rheumatol Int       Date:  2017-07-27       Impact factor: 2.631

Review 2.  An update on the role of epigenetics in systemic vasculitis.

Authors:  Patrick Coit; Haner Direskeneli; Amr H Sawalha
Journal:  Curr Opin Rheumatol       Date:  2018-01       Impact factor: 5.006

3.  Serum Cytokine Levels in Behçet's Disease.

Authors:  Zeynep Meltem Akkurt; Mehtap Bozkurt; Derya Uçmak; Hatice Yüksel; Haydar Uçak; Bilal Sula; Zeynep Gürsel Özkurt; Mehmet Yildiz; Dicle Akdeniz; Mustafa Arica
Journal:  J Clin Lab Anal       Date:  2014-08-17       Impact factor: 2.352

4.  Panax Notoginseng Saponin Controls IL-17 Expression in Helper T Cells.

Authors:  Jia-Ru Wei; Xiaofeng Wen; Paul W Bible; Zhiyu Li; Robert B Nussenblatt; Lai Wei
Journal:  J Ocul Pharmacol Ther       Date:  2017-01-04       Impact factor: 2.671

5.  Activation of the JAK/STAT pathway in Behcet's disease.

Authors:  A Tulunay; M G Dozmorov; F Ture-Ozdemir; V Yilmaz; E Eksioglu-Demiralp; F Alibaz-Oner; G Ozen; J D Wren; G Saruhan-Direskeneli; A H Sawalha; H Direskeneli
Journal:  Genes Immun       Date:  2014-11-20       Impact factor: 2.676

6.  Soluble levels of osteopontin in patients with Behcet's disease: association with disease activity and vascular involvement.

Authors:  Iman H Bassyouni; Mohammed M El-Wakd; Rasha H Bassyouni
Journal:  J Clin Immunol       Date:  2012-10-25       Impact factor: 8.317

Review 7.  The immunogenetics of Behçet's disease: A comprehensive review.

Authors:  Masaki Takeuchi; Daniel L Kastner; Elaine F Remmers
Journal:  J Autoimmun       Date:  2015-09-05       Impact factor: 7.094

8.  Behçet's disease: immunological relevance with arthritis of ankylosing spondylitis.

Authors:  Esin Aktas Cetin; Fulya Cosan; Umut Can Kucuksezer; Sema Bilgic; Yonca Cagatay; Ahmet Gul; Gunnur Deniz
Journal:  Rheumatol Int       Date:  2012-05-11       Impact factor: 2.631

9.  Development of Immunopathogenesis Strategies to Treat Behçet's Disease.

Authors:  Osman Köse
Journal:  Patholog Res Int       Date:  2012-04-03

10.  Copy number variants and genetic polymorphisms in TBX21, GATA3, Rorc, Foxp3 and susceptibility to Behcet's disease and Vogt-Koyanagi-Harada syndrome.

Authors:  Dan Liao; Shengping Hou; Jun Zhang; Jing Fang; Yunjia Liu; Lin Bai; Qingfeng Cao; Aize Kijlstra; Peizeng Yang
Journal:  Sci Rep       Date:  2015-04-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.